Select Medical Enters Acquisition Agreement Amid Strong 2026 Revenue Outlook

Select Medical (SEM) has announced a definitive agreement to be acquired by a consortium of investors. The group is led by the company's Executive Chairman, Robert Ortenzio, in partnership with Martin Jackson and the private equity firm Welsh, Carson, Anderson & Stowe. The acquisition news was disclosed during the company's Q1 2026 earnings call, marking a pivotal shift in the organization's corporate structure. The move to a consortium-led ownership suggests a strategic transition toward private management under the guidance of existing leadership. In addition to the buyout news, the company provided concrete financial guidance for the coming years. Select Medical expects its 2026 revenue to reach between $5.6 billion and $5.8 billion, signaling steady growth expectations despite the change in ownership. To support this financial trajectory, the company is focusing on infrastructure expansion. Management outlined plans to add 275 additional beds to its facilities through 2027, ensuring the company can meet increasing demand for its specialized medical services. Market participants will likely view the acquisition as a catalyst for immediate price stability around the offer value, while the revenue and capacity targets underscore the company's underlying operational strength.